BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sophocleous RA, Ooi L, Sluyter R. The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target. Int J Mol Sci 2022;23:5739. [PMID: 35628550 DOI: 10.3390/ijms23105739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sophocleous RA, Sluyter R. From dolphins to dogs: new opportunities to understand the role of P2X4 receptors in spinal cord injury and neuropathic pain. Neural Regen Res 2023;18:1497-8. [PMID: 36571351 DOI: 10.4103/1673-5374.360294] [Reference Citation Analysis]
2 Hu Q, Li G. Role of purinergic receptors in cardiac sympathetic nerve injury in diabetes mellitus. Neuropharmacology 2023;226:109406. [PMID: 36586475 DOI: 10.1016/j.neuropharm.2022.109406] [Reference Citation Analysis]
3 Sluyter R, Sophocleous RA, Stokes L. P2X receptors: Insights from the study of the domestic dog. Neuropharmacology 2023;224:109358. [PMID: 36464207 DOI: 10.1016/j.neuropharm.2022.109358] [Reference Citation Analysis]
4 Khairullin AE, Grishin SN, Ziganshin AU. P2 Receptor Signaling in Motor Units in Muscular Dystrophy. Int J Mol Sci 2023;24. [PMID: 36675094 DOI: 10.3390/ijms24021587] [Reference Citation Analysis]
5 Paul A, Kumar M, Das P, Guha N, Rudrapal M, Zaman MK. Drug repurposing – A search for novel therapy for the treatment of diabetic neuropathy. Biomedicine & Pharmacotherapy 2022;156:113846. [DOI: 10.1016/j.biopha.2022.113846] [Reference Citation Analysis]
6 Cuthbertson P, Elhage A, Al-Rifai D, Sophocleous RA, Turner RJ, Aboelela A, Majed H, Bujaroski RS, Jalilian I, Kelso MJ, Watson D, Buckley BJ, Sluyter R. 6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist. Biomolecules 2022;12:1309. [PMID: 36139148 DOI: 10.3390/biom12091309] [Reference Citation Analysis]